The latest news and science from the 12 journals of the American Heart Association.

Latest Posts

Circulation: Arrhythmia and Electrophysiology Cir AE Feb 2016 featured articles.jpg
New Featured Articles

Outcome of Apparently Unexplained Cardiac Arrest: Results From Investigation and Follow-Up of the Prospective Cardiac Arrest Survivors With Preserved Ejection Fraction Registry

Impact of Complete Versus Incomplete Circumferential Lines Around the Pulmonary Veins During Catheter Ablation of Paroxysmal Atrial Fibrillation: Results From the Gap-Atrial Fibrillation%u2013German Atrial Fibrillation Competence Network 1 Trial

 

More Issues. More Impact. More Opportunity.

 

Circulation: Arrhythmia and Electrophysiology has increased its frequency! It is now published monthly.

 

The journal is continuously published, which means that articles are available online sooner. Twelve issues per year means that articles will be deposited more rapidly into the Science Citation Index. As a monthly publication, more issues mean more content. Editorials and reviews will highlight opinions, put articles into context, and summarize topics of contemporary interest to the clinician.

Sign up for electronic alerts (eAlerts) to be notified when new content is available: http://www.ahajournals.org/cgi/alerts/etoc http://circep-submit.aha-journals.org

Related Links:

arrhyth_ipad_banner.jpg
Posted by Stacey SIMS on Feb 2, 2016 2:20 PM CST
Circ INTV cov Jan 2016.png
New Featured Articles from Circulation: Cardiovascular Interventions

Bivalirudin Is Associated With Improved In-Hospital Outcomes Compared With Heparin in Percutaneous Vascular Interventions
http://circinterventions.ahajournals.org/content/9/1/e002823.full

Clopidogrel Versus Aspirin as an Antiplatelet Monotherapy After 12-Month Dual-Antiplatelet Therapy in the Era of Drug-Eluting Stents
http://circinterventions.ahajournals.org/content/9/1/e002816.full

 

New Expedited Review and Publication Track from Circulation: Cardiovascular Interventions

 

Circulation: Cardiovascular Interventions is pleased to announce the addition of an expedited review and publication option for authors of high-impact research.

 

Expedited Publication: The purpose of this section is to provide authors an avenue through which to rapidly publish original work that communicates novel, influential, and clinically impactful research. Submissions of standard-length original research will be considered.

In order to be considered for this expedited track, authors must send a request for consideration via email to circ@circulationjournal.orghref>; this request must include a cover letter that details why expedited review and publication are warranted, as well as a draft of the manuscript. The editors will decide whether the manuscript is appropriate for expedited processing within 48 hours of receipt. If approved, the paper should be submitted to the journal's submission site, http://circinterventions-submit.aha-journals.orghref>; an initial decision regarding publication will be made within 7 days of formal submission. If revisions are required, authors will have 5 days to resubmit the paper. If accepted, the paper will publish within 16 business days of acceptance.

Authors of manuscripts not offered expedited consideration may still submit their work via the standard review process.

Related Links:

Posted by Stacey SIMS on Feb 1, 2016 2:36 PM CST
JAHA cov Jan 2016.png
New Featured Articles from JAHA: Journal of the American Heart Association

Consumption of Caffeinated Products and Cardiac Ectopy
http://jaha.ahajournals.org/content/5/1/e002503.full

Related Editorial
Caffeine Consumption and Cardiovascular Risks: Little Cause for Concern
http://jaha.ahajournals.org/content/5/1/e003089.full

Impact of Nonoptimal Intakes of Saturated, Polyunsaturated, and Trans Fat on Global Burdens of Coronary Heart Disease
http://jaha.ahajournals.org/content/5/1/e002891.full

JAHA-Web-Banners-650x100-2.jpg

Posted by Stacey SIMS on Jan 29, 2016 3:04 PM CST
hypertension cov Dec 2016 png with rule.
Hypertension Guidelines Debate: Influential Studies and Best Practices

Over the next few months, Hypertension will seek opinions and comments from key leaders involved in regional and international hypertension guidelines. Views from across the world on the potential impact of the new findings of lower systolic blood pressure targets and future guidelines will be shared. Through this platform, Hypertension will serve the hypertension community by keeping readers abreast of how the new landmark studies will influence major guidelines and decision making for best practice.

Read the entire article from Editor-in-Chief Anna F. Dominiczak and Deputy Editor Rhian M. Touyz introducing the new platform at Hypertension.

Hypertension Guidelines Debate: Is It Time to Reappraise Blood Pressure Thresholds and Targets?
Rhian M. Touyz, Anna F. Dominiczak

http://hyper.ahajournals.org/content/early/2016/01/25/HYPERTENSIONAHA.116.07090.full.pdf

For more detailed information, please contact the journal at hypertension@heart.org
Posted by Stacey SIMS on Jan 27, 2016 2:26 PM CST

Call for Papers
Big Data-Themed Issue

Circulation: Cardiovascular
Quality and Outcomes

 

 Circ CQO Jan 2014


Call for Papers: Big Data-Themed Issue

Circulation: Cardiovascular Quality and Outcomes welcomes the submission of manuscripts focusing on the topic of big data.  All submissions will receive expedited consideration for publication in a special focus issue, which will publish in the spring.

We are looking for Perspectives, Original Research, Methods, and Visualizations. We are eager for content about how this approach is changing research and clinical care.

Deadline for Submission: Tuesday, March 1, 2016

URL for Submission: http://circoutcomes-submit.aha-journals.org

If submitted on-time, your manuscript will undergo an initial screening by the editors to determine its suitability for publication in the journal. Please indicate in your cover letter that the manuscript is intended for this series.

For more detailed information, please contact the journal at circ@circulationjournal.org.

For more information on submitting a manuscript, please visit our Instructions to Authors.


Related Links:

Circ_Quality_Outcomes_iPad_app_728x90.JP

Posted by Stacey SIMS on Jan 13, 2016 3:21 PM CST

American Journal of Nephrology

Free-Access Articles

(Vol. 42, issues 1-4, 2015)

Special service from Karger Publishers for the readers of Hypertension

Editorials

Serum S100A12: A Risk Marker or Risk Factor of Vascular Calcification in Chronic Kidney Disease?
B. Lindholm
Am J Nephrol 2015;42:1-3

Why Is the Association of Phosphorus and FGF23 with Mortality Stronger in African-American Hemodialysis Patients?
W. L. Lau,K.  Kalantar-Zadeh
Am J Nephrol 2015;42:22-24

Predicting Mortality after Severe Acute Kidney Injury: A Step Forward but Not Close to the Finish Line
S. Sharma, S.D. Navaneethan
Am J Nephrol 2015;42:54-56

Placental Growth Factor as a Novel Marker in Uremia-Related Cardiovascular Disease 
C.W. Chen, S.A. Karumanchi
Am J Nephrol 2015;42:115-116

Non-Adherence Codes in the New ICD-10: Need for Prospective Trials 
L.S. Baines, D.J. Little, R. Nee, R.M. Jindal
Am J Nephrol 2015;42:148-150

Cardiac Electromechanical Abnormalities in Hemodialysis Patients: Indicators of Cardiomyopathy and Future Risk? 
M.K. Fallahzadeh, P.A. McCullough
Am J Nephrol 2015;42:237-238

Acute Kidney Injury: A Modifiable Risk Factor for Cardiovascular Morbidity and Mortality 
G. Alreja, J.L. Koyner
Am J Nephrol 2015;42:282-284

Antioxidants Therapy for Patients with Chronic Kidney Disease: A Question of Balance 
J. Chen, R. Siriki
Am J Nephrol 2015;42:318-319

Original Reports: Patient-Oriented, Translational Research

Serum S100A12 and Progression of Coronary Artery Calcification Over 4 Years in Hemodialysis Patients 
Y. Wang, Y Sun, Y. Wang, Y. Jia
Am J Nephrol 2015;42:4-1

Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy 
S.A.M.E.G. Timmermans, M.A.  Abdul Hamid, J.W. Cohen Tervaert, J.G.M.C. Damoiseaux, P. van Paassen, on behalf of the Limburg Renal Registry
Am J Nephrol 2015;42:70-77

In-Depth Topic Review

Treatment Failure of Active Vitamin D Therapy in Chronic Kidney Disease: Predictive Factors 
M. Cozzolino, A. Covic, B. Martinez-Placencia, K. Xynos
Am J Nephrol 2015;42:228-236

Nephrology Grand Rounds

Two Novel HOGA1 Splicing Mutations Identified in a Chinese Patient with Primary Hyperoxaluria Type 3
X. Wang, X. Zhao, X. Wang, J. Yao, F. Zhang, Y. Lang, S. Tuffery-Giraud, I. Bottillo, L. Shao
Am J Nephrol 2015;42:78-84

Hypomagnesemia as First Clinical Manifestation of ADTKD-HNF1B: A Case Series and Literature Review 
C.I. van der Made, E.J. Hoorn, R. de la Faille, H. Karaaslan,  N.V.A.M. Knoers, J.G.J. Hoenderop, R. Vargas Poussou, J.H.F. de Baaij
Am J Nephrol 2015;42:85-90

Announcement

KARGER-OLA MONTHLY BLOGS  
Am J Nephrol 2014;40:39

American Journal of Nephrology
Managing Editor: G.L. Bakris, Chicago, Ill.

The American Journal of Nephrology mainly focuses on timely topics in basic science with possible clinical applicability. Its current impact factor is 2.658

For subscriptions, sign-ups to ToC Alerts, library recommendations or submission of articles, please go to the journal's homepage

Related Sites
Council on Hypertension
Council on the Kidney in Cardiovascular Disease

728x90_AHAstats.jpg

Posted by Stacey SIMS on Dec 22, 2015 10:23 AM CST
New Free Editor's Picks from Circulation: Cardiovascular Genetics

Green Tea Catechin Normalizes the Enhanced Ca2+ Sensitivity of Myofilaments Regulated by a Hypertrophic Cardiomyopathy–Associated Mutation in Human Cardiac Troponin I (K206I)
Abstract | Full Text | PDF | Data Supplement

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody
Abstract | Full Text | PDF | Data Supplement

Functional Genomics Analysis of Big Data Identifies Novel Peroxisome Proliferator–Activated Receptor γ Target Single Nucleotide Polymorphisms Showing Association With Cardiometabolic Outcomes
Abstract | Full Text | PDF | Data Supplement

Posted by Stacey SIMS on Dec 16, 2015 3:31 PM CST
New Free Editor's Picks from Circulation: Cardiovascular Arrhythmia and Electrophysiology

Mechanisms for the Termination of Atrial Fibrillation by Localized Ablation: Computational and Clinical Studies
Abstract | Full Text | PDF | Data Supplement

Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation
Abstract | Full Text | PDF | Data Supplement

Characterization of the Left-Sided Substrate in Arrhythmogenic Right Ventricular Cardiomyopathy
Abstract | Full Text | PDF

Posted by Stacey SIMS on Dec 16, 2015 2:35 PM CST
New Free Editor's Picks from Circulation: Cardiovascular Arrhythmia and Electrophysiology

 

 

 

Atrial Fibrillation Burden and Short-Term Risk of Stroke: Case-Crossover Analysis of Continuously Recorded Heart Rhythm From Cardiac Electronic Implanted Devices
Abstract | Full Text | PDF | Data Supplement

Time Course of Atrial Fibrillation in Patients With Congenital Heart Defects
Abstract | Full Text | PDF

Arrhythmia Termination Versus Elimination of Dormant Pulmonary Vein Conduction as a Procedural End Point of Catheter Ablation for Paroxysmal Atrial Fibrillation: A Prospective Randomized Trial
Abstract | Full Text | PDF

Posted by Stacey SIMS on Dec 15, 2015 8:22 PM CST
< Prev    1 2 3 4 5 6 7 8 9 ... 27   

Most Recent Comments

http://networking.americanheart.org/blogs/47/1122
Stacey, will the Stroke webinars be recorded and available later? Many members at our hospital are not able to commit to 7am PST.